Alcami Capacity Update May 2024: Fill/Finish

Alcami is a globally recognized CDMO that partners with clients to bring life-changing medicines to patients. We deliver reliable solutions that unlock the potential of transformative medicines from discovery to commercialization through trusted partnerships with our clients, recognized industry expertise, and a proven regulatory track record. Alcami’s development and manufacturing capabilities support small and large molecules, lyophilized products, complex formulations, and DEA-scheduled drug products. In addition to sterile fill finish (parental) capabilities, Alcami also offers oral solid dose development, solid state characterization, clinical manufacturing, batch scale up, and commercial manufacturing.

Alcami offers sterile drug product fill finish services including, but not limited to, formulation development, complex formulations, clinical manufacturing, batch scale up, and commercial manufacturing. Utilizing isolator and RABs technologies, sterile drug product (DP) filling facilities consisting of multiple aseptic filling lines are capable of manufacturing liquid and lyophilized vials as well as prefilled syringes. Additional capabilities include terminal sterilization, single use systems, annex 1 compliance, temperature/oxygen sensitive compounding and controlled drug Schedule I-V manufacture.